Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 2
2004 2
2005 4
2006 1
2007 2
2008 1
2009 1
2010 2
2011 1
2012 1
2013 5
2014 2
2015 7
2016 5
2017 10
2018 12
2019 4
2020 1
2021 1
2022 3
2023 4
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

65 results

Results by year

Filters applied: . Clear all
Page 1
Long-Term Effectiveness of Galcanezumab in the Prevention of Migraine: An Italian Retrospective Analysis (REALITY).
Vernieri F, Iannone LF, Guerzoni S, Russo A, Barbanti P, Sances G, Cevoli S, Rao R, Lovati C, Ambrosini A, Buzzoni C, Battisti F, Vatteone L, King SML, Torelli F. Vernieri F, et al. Among authors: ambrosini a. Neurol Ther. 2024 Apr;13(2):415-435. doi: 10.1007/s40120-024-00582-0. Epub 2024 Feb 8. Neurol Ther. 2024. PMID: 38329615 Free PMC article.
Development and validation of a new standardized measure for assessing experiences of discrimination within mental health services. A participatory research project.
Lasalvia A, Pillan S, Marzocco G, Ambrosini A, Veltro F, Pozzan T, D'Astore C, Cristofalo D, Ruggeri M, Bonetto C; Mental Health Service Users’ Association ‘Il Cerchio Aperto’. Lasalvia A, et al. Among authors: ambrosini a. Epidemiol Psychiatr Sci. 2023 Sep 8;32:e54. doi: 10.1017/S2045796023000689. Epidemiol Psychiatr Sci. 2023. PMID: 37681529 Free PMC article.
Harassment in the headache field: a global web-based cross-sectional survey.
de Boer I, Ambrosini A, Halker Singh RB, Baykan B, Buse DC, Tassorelli C, Jensen RH, Pozo-Rosich P, Terwindt GM; International Headache Society Women’s Leadership Forum. de Boer I, et al. Among authors: ambrosini a. Cephalalgia. 2023 Aug;43(8):3331024231193099. doi: 10.1177/03331024231193099. Cephalalgia. 2023. PMID: 37652444 Free article.
The positive impact on translational research of Fondazione italiana di ricerca per la Sclerosi Laterale Amiotrofica (AriSLA), a non-profit foundation focused on amyotrophic lateral sclerosis. Convergence of ex-ante evaluation and ex-post outcomes when goals are set upfront.
Guareschi S, Ravasi M, Baldessari D, Pozzi S, Zaffino T, Melazzini M, Ambrosini A. Guareschi S, et al. Among authors: ambrosini a. Front Res Metr Anal. 2023 Aug 4;8:1067981. doi: 10.3389/frma.2023.1067981. eCollection 2023. Front Res Metr Anal. 2023. PMID: 37601533 Free PMC article.
Perceived barriers to career progression in the headache field: A global web-based cross-sectional survey.
de Boer I, Ambrosini A, Halker Singh RB, Baykan B, Buse DC, Tassoreli C, Jensen RH, Pozo-Rosich P, Terwindt GM; International Headache Society Women’s Leadership Forum. de Boer I, et al. Among authors: ambrosini a. Cephalalgia. 2022 Dec;42(14):1498-1509. doi: 10.1177/03331024221123081. Epub 2022 Sep 7. Cephalalgia. 2022. PMID: 36071614 Free PMC article.
Preventive pharmacological treatment in subjects at risk for fatal familial insomnia: science and public engagement.
Forloni G, Roiter I, Artuso V, Marcon M, Colesso W, Luban E, Lucca U, Tettamanti M, Pupillo E, Redaelli V, Mariuzzo F, Boscolo Buleghin G, Mariuzzo A, Tagliavini F, Chiesa R, Ambrosini A. Forloni G, et al. Among authors: ambrosini a. Prion. 2022 Dec;16(1):66-77. doi: 10.1080/19336896.2022.2083435. Prion. 2022. PMID: 35737759 Free PMC article.
Changes in acute headache medication use and health care resource utilization: Results from a randomized, double-blind, placebo-controlled clinical trial evaluating galcanezumab in adults with treatment-resistant migraine (CONQUER).
Ambrosini A, Estemalik E, Pascual J, Rettiganti M, Stroud C, Day K, Ford J. Ambrosini A, et al. J Manag Care Spec Pharm. 2022 Jun;28(6):645-656. doi: 10.18553/jmcp.2022.21375. Epub 2022 Apr 22. J Manag Care Spec Pharm. 2022. PMID: 35451858 Clinical Trial.
65 results